Evidence map›Paper›PMID 33754052›Full record

ArticleTheranostics2021

MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.

Jun Liu, Szu-Jung Chen, Ssu-Wei Hsu, Jun Zhang, Ji-Min Li, David C Yang, Shenwen Gu, Kent E Pinkerton, Ching-Hsien Chen

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. International journal of general medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jun LiuDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Szu-Jung ChenDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Ssu-Wei HsuDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Jun ZhangDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Ji-Min LiDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
David C YangDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Shenwen GuDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
Kent E PinkertonCenter for Health and the Environment and Department of Pediatrics, University of California Davis, Davis, CA, USA.
Ching-Hsien ChenDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine and Center for Comparative Respiratory Biology and Medicine, University of California Davis, Davis, California, USA.
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI KC KENT LLOYD · 2002 to 2026
$84.9M
Novel role of phospho-MARCKS in macrophages during tobacco smoke-driven fibrosisR01HL146802 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Ching-Hsien Chen · 2019 to 2026
$2.6M
NCI NIH HHS P30 CA093373NHLBI NIH HHS R01 HL146802
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

A549 CellsAnimalsCell Line, TumorCigarette SmokingEpithelial-Mesenchymal TransitionHumansLung NeoplasmsMyristoylated Alanine-Rich C Kinase SubstrateNF-kappa BPhosphorylationPrimatesRepressor ProteinsSignal TransductionSmokeMARCKS protein, humanMyristoylated Alanine-Rich C Kinase SubstrateNF-kappa BNKAP protein, humanRepressor ProteinsSmokecigarette smokinglung cancerMARCKSNF-κBNKAP

Identifiers

PMID33754052
PMCPMC7977464
OpenAlexW3139272128

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.